Score Your Stock

LYC LYC HEALTHCARE BERHAD

0075.KL · Health Care · Health Care Providers
Bottom 37% of scored stocks
Compare with nearby peers
OkayBottom 37% of scored stocks
Profit SpikeRecent Loss

LYC scores 42/100 on fundamentals: in the bottom 37% of 1120 scored Bursa Malaysia stocks. Its strongest area is Risk (58/100); its weakest is Business Strength (30/100). It carries 2 warning flags: Profit Spike, Recent Loss.

Best
Risk 58
Weakest
Business 30
  • Carries a Profit Spike flag
  • Carries a Recent Loss flag
Mkt capRM 11.1m#1094 of 1113 in BursaEPSRM -1.50P/En/m (loss-making)✓ vs sector avg 26.2×P/B0.8×✓ vs sector avg 1.8×Div yieldNo dividends paidBottom 30% in Bursa52w range · 33% of range0.010.04
as of 18 Oct 2026

Nearby peers

Ranks #20 of 30 in Health Care by score

#1DPHARMA85#18TOPVISN44#19LACMED44
#20LYC42
#21SMILE41#22IHH40

One-Minute Summary

Why LYC scores 42

A financially stretched, expensively priced stock, but business strength needs attention.

What looks good
What to watch

After Jun '26 results: 31 → 33+2· Debt-to-Equity Weak → StrongSee all movers →

Business StrengthLowest pillar

30
Why 30?
Pillar score: (1 + 2 + 0 + 0 + 0) = 3 of 10 points → 30
Return on Equity (ROE)216%Okay4-Year Revenue Growth+14%/yrStrong4-Year Profit Growthn/m (loss-making)WeakNet Profit Marginn/m (loss-making)WeakQuarterly Momentumn/m (loss-making)Weak
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↓ -19.3%Equity ↓ -123.8%ROE % -112.5%
Net ProfitEquityROE %
-19m-21m-17m-23m45m35m15m-11m2023202420252026-43%-59.4%-112.5%

Revenue & Net Profit, with Net Margin

Revenue ↑ +46.4%Net Profit ↓ -19.3%Net Margin % -17%
RevenueNet ProfitNet Margin %
92m129m156m135m-19m-21m-17m-23m2023202420252026-20.8%-16.1%-11%-17%

Sales grew about 46.4% over 4 years: customers keep spending more with this company.

The company lost money in recent years: the bars below zero are losses, not profits.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↓ -18.2%Net Profit ↓ -14.3%Net Margin % -9.4%
RevenueNet ProfitNet Margin %
42m41m34m32m33m36m34m34m-3m-2m-8m-4m-4m-4m-10m-3mSep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26-6.7%-6.2%-24.9%-14%-12.7%-11.8%-31%-9.4%
▼▼▼▼▼▼▼▼

Sales fell about 18.2% over the last 8 quarters: worth watching why.

The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.

Why 33?
Pillar score: (2 + 0 + 0) = 2 of 6 points → 33
Debt-to-Equity-4.7×StrongCurrent Ratio0.4×WeakInterest Coverage0.1×Weak
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↓ -52.3%Equity ↓ -123.8%D/E 5.4×
Total DebtEquityD/E
104m77m82m50m45m35m15m-11m20232024202520262.3×2.2×5.4×

Borrowings fell about 52.3% over 4 years: the company is steadily getting safer.

Short-term assets vs bills, with Current Ratio

Current Assets ↓ -17.9%Current Liabilities ↑ +233.8%Current Ratio 0.4×
Current AssetsCurrent LiabilitiesCurrent Ratio
66m61m54m54m38m115m117m127m20232024202520261.7×0.5×0.5×0.4×
Why 50?
Pillar score: (0 + 2 + 2 + 0) = 4 of 8 points → 50
Dividend QualityNo dividends paidWeak
Payout ratio: -0%
Operating Cash FlowPositive & growingStrongFree Cash FlowPositive & growingStrongCash & Cash EquivalentsShrinking & thinWeak
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↑ +470%Free CF ↑ +864%
Operating CFFree CF
5m11m28m29m3m5m23m24m2023202420252026

The business generates real cash, and more of it each year: a very healthy sign.

Cash vs Total Debt

Cash ↓ -81.3%Short-Term Debt ↑ +1,033.3%Total Debt ↓ -52.3%
CashShort-Term DebtTotal Debt
40m15m8m8m1m11m10m10m104m77m82m50m2023202420252026

Dividends per Share, with Yield

DPS (sen) → +0%Yield % 0%
DPS (sen)Yield %
000020222023202420250%0%0%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 33?
Pillar score: (0 + 2 + 0) = 2 of 6 points → 33
P/E Ration/m (loss-making)WeakP/B Ratio0.8×StrongPEG Ration/m (growth not measurable)Weak
Show chart

Score vs Share Price

Score (0-100)Share price
RM 0.03RM 0.02RM 0.01100500Oct '25Feb '26Jun '26Oct '26📊

The share price is down about 40% over the past year.

What happened, and how the price moved

Why 58?
Pillar score: (0 + 2 + 1 + 2 + 2 + 0) = 7 of 12 points → 58
Earnings ConsistencyVery bumpyWeakDebt Trend (4yr)FallingStrongShare Count Trend (4yr)+4%/yrOkayInventory vs Sales (4yr)-11.4 pp/yr vs salesStrongAsset Turnover Trend (4yr)+58.5%StrongQuarterly ConsistencyLoss in 8 of 8 quartersWeak
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +46.4%Inventory ↑ +6.4%Inv. % of Rev. 6.1%
RevenueInventoryInv. % of Rev.
92m129m156m135m8m12m9m8m20232024202520268.5%8.9%5.7%6.1%

Get an email when LYC's score changes, and why

Own more than one stock? Check them all at once ›
Ranks #20 of 30 in Health Care by score

Sector peers

#1DPHARMA85#18TOPVISN44#19LACMED44
#20LYC (you)42
#21SMILE41#22IHH40

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDiv yieldP/E RatioP/B Ratio
2026RM 135.1mRM -22.9mRM 28.5mRM 24.1mRM -4.4mRM 7.5mRM 49.7mRM 10.2mRM -10.6mRM 54.4mRM 126.5mRM 198.0mRM 159.2mRM 8.3m-216%-17%-4.7×0.4×0.1×0%-0.5×-1.0×
2025RM 155.5mRM -17.1mRM 28.4mRM 22.7mRM -5.6mRM 7.7mRM 81.8mRM 10.4mRM 15.2mRM 53.7mRM 117.2mRM 235.3mRM 179.6mRM 8.9mRM 0.0m-112%-11%5.4×0.5×0.3×0%-2.9×3.3×
2024RM 129.0mRM -20.8mRM 10.7mRM 5.0mRM -5.7mRM 14.7mRM 76.9mRM 10.6mRM 35.0mRM 61.4mRM 114.7mRM 250.5mRM 176.9mRM 11.5mRM 0.0m-59%-16%2.2×0.5×-0.3×0%-6.4×3.8×
2023RM 92.3mRM -19.2mRM 5.0mRM 2.5mRM -2.5mRM 40.2mRM 104.3mRM 0.9mRM 44.6mRM 66.3mRM 37.9mRM 214.4mRM 136.1mRM 7.8mRM 0.0m-43%-21%2.3×1.8×0.0×0%-8.8×3.8×